BRIEF published on 04/09/2026 at 18:05, 29 days 17 hours ago First quarter 2026 review for i2S Revenue Growth I2S Export Twiga
BRIEF published on 04/09/2026 at 18:05, 29 days 17 hours ago Bilan du premier trimestre 2026 pour i2S Chiffre D'affaires Croissance I2S Exportation Twiga
REGULATED PRESS RELEASE published on 04/09/2026 at 18:00, 29 days 17 hours ago i2S : Chiffre d'Affaires T1 2026 Progression de 2,35% des ventes au T1 2026 pour i2S. Entrées de commandes en hausse de 55%. Confiance dans la croissance rentable. Détails sur les activités DigiBook, Orphie, Vision et MedCare Croissance Ventes I2S Orphie DigiBook
BRIEF published on 03/24/2026 at 18:05, 1 month 15 days ago I2S: 2025 Annual Results Growth Strategy Gross Margin R&D I2S 2025 Financial Results
BRIEF published on 03/24/2026 at 18:05, 1 month 15 days ago I2S : Résultats annuels 2025 Stratégie De Croissance R&D Marge Brute I2S Résultats Financiers 2025
REGULATED PRESS RELEASE published on 03/24/2026 at 18:00, 1 month 15 days ago i2S : Résultats annuels 2025 Performance solide pour i2S en 2025 malgré un environnement économique difficile, avec des ratios de rentabilité préservés et une solidité financière renforcée Croissance Rentabilité Performance Solidité Financière I2S
BRIEF published on 01/23/2026 at 18:05, 3 months 16 days ago I2S: 2025 revenue slightly down Revenue I2S Exports Twiga ORPHIA
BRIEF published on 01/23/2026 at 18:05, 3 months 16 days ago I2S : Chiffre d'affaires 2025 en légère baisse Chiffre D'affaires I2S Orphie Exportations Twiga
REGULATED PRESS RELEASE published on 01/23/2026 at 18:00, 3 months 16 days ago i2S : Chiffre d'affaires 2025 i2S confirme la solidité de son modèle économique en maintenant la profitabilité malgré une baisse des ventes. Des disparités selon les activités, notamment avec la forte progression des produits TWIGA et ORPHIE Profitabilité I2S Modèle Économique Orphie Twiga
BRIEF published on 10/16/2025 at 18:05, 6 months 23 days ago I2S : Croissance au 3e trimestre malgré un recul annuel Chiffre D'affaires Croissance I2S Export Marque I2S
Published on 05/09/2026 at 01:30, 10 hours 16 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 11 hours 46 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 15 hours 7 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 16 hours 33 minutes ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 16 hours 43 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 16 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 1 day 16 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 1 day 16 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 1 day 16 hours ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 1 day 16 hours ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
